University of Iowa Hospitals and Clinics

Lumos to Highlight New LUM-201 Data and Analysis Presented at ENDO 2023 in Virtual KOL Webinar

Retrieved on: 
Wednesday, June 21, 2023

AUSTIN, Texas, June 21, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for idiopathic Pediatric Growth Hormone Deficiency (iPGHD) through Phase 2 clinical trials, is hosting today a virtual Key Opinion Leader (KOL) Webinar where Drs. Fernando Cassorla and Michael Tansey will highlight the encouraging new data and analysis on oral LUM-201 for idiopathic PGHD from the Phase 2 PK/PD OraGrowtH212 and dose-finding OraGrowtH210 Trials presented at the Endocrine Society (ENDO) Annual Meeting, held in Chicago, Illinois, June 15-18, 2023.

Key Points: 
  • Fernando Cassorla and Michael Tansey will highlight the encouraging new data and analysis on oral LUM-201 for idiopathic PGHD from the Phase 2 PK/PD OraGrowtH212 and dose-finding OraGrowtH210 Trials presented at the Endocrine Society (ENDO) Annual Meeting, held in Chicago, Illinois, June 15-18, 2023.
  • Cassorla and Tansey will be available to answer questions following their formal presentations.
  • To register for the virtual KOL Event, please click through the link HERE .
  • Cassorla and Tansey gave two oral presentations in the Update on Growth Disorders session at the 2023 ENDO Meeting.

Lumos Pharma Announces Abstracts Accepted for Oral Presentation at 2023 ENDO Meeting with Virtual KOL Event to be Held on June 21st

Retrieved on: 
Thursday, May 25, 2023

Lumos Pharma will host a virtual Key Opinion Leader (KOL) Webinar on June 21, 2023, 11:00 AM – 12 PM EDT where Drs.

Key Points: 
  • Lumos Pharma will host a virtual Key Opinion Leader (KOL) Webinar on June 21, 2023, 11:00 AM – 12 PM EDT where Drs.
  • Fernando Cassorla and Michael Tansey will review interim data evaluating oral LUM-201 for idiopathic PGHD from the Phase 2 PK/PD OraGrowtH212 and dose-finding OraGrowtH210 Trials presented at the ENDO Meeting.
  • is currently Chief of Pediatric Endocrinology at the Institute of Maternal and Child Research of the University of Chile, a position he has held since 1993.
  • Dr. Tansey also currently serves as Clinical Director for Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Iowa.

PrecisionOS Revolutionizes Orthopedic Residency Education with Immersive Virtual Reality Surgical Curriculum

Retrieved on: 
Tuesday, March 7, 2023

VANCOUVER, BC, March 7, 2023 /PRNewswire/ - PrecisionOS®, a leading medical education simulation provider announced today a novel virtual reality curriculum for orthopedic training.

Key Points: 
  • VANCOUVER, BC, March 7, 2023 /PRNewswire/ - PrecisionOS®, a leading medical education simulation provider announced today a novel virtual reality curriculum for orthopedic training.
  • The company has put together an extensive guide aimed at all residency programs in North America and beyond.
  • "This virtual reality curriculum represents a true game-changer in surgical education," said Dr. Peter Ferguson, Albert and Temmy Latner Chair of the Division of Orthopedics, Department of Surgery, University of Toronto.
  • This virtual reality curriculum is now available for all orthopedic surgical residency programs in North America and will be released at the American Academy of Orthopedic Surgeons Annual Meeting in Las Vegas March 7-11, 2023.

Andrew Freese, MD, is recognized by Continental Who's Who

Retrieved on: 
Thursday, October 6, 2022

A lifelong sports fan, Andrew Freese, MD, offers cutting-edge sports medicine to individuals and sports teams in Texas.

Key Points: 
  • A lifelong sports fan, Andrew Freese, MD, offers cutting-edge sports medicine to individuals and sports teams in Texas.
  • He treats complex sports injuries at AOA Orthopedic Specialists and the University of Texas Arlington, the most extensive Orthopedic Practice in Northern Texas.
  • AOA Orthopedic Specialists, founded in 1996, is known for its all-inclusive approach to spine medicine, orthopedic care, physical therapy, and sports injury medicine.
  • Dr. Freese would like to dedicate this honorable recognition to Ernie Fernandez, MD, the doctor's pediatrician and inspiration in becoming a physician.

Dr. Lawrence Garcia Joins The Vascular Care Group, Newton-Wellesley

Retrieved on: 
Tuesday, September 20, 2022

The Vascular Care Group, a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Dr. Lawrence Garcia has joined the Wellesley center.

Key Points: 
  • The Vascular Care Group, a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Dr. Lawrence Garcia has joined the Wellesley center.
  • Lawrence A. Garcia, MD, FACC, FAHA, FSCAI, is a Board-certified interventional cardiologist with a focus on peripheral vascular disease.
  • Prior to joining The Vascular Care Group, Dr. Garcia received his undergraduate and doctoral degrees from the University of Arizona.
  • The Vascular Care Group (TVCG) is a growing group practice committed to the prevention, diagnosis and treatment of vascular disease.

Andrew Freese, MD, is being recognized by Continental Who's Who

Retrieved on: 
Monday, June 6, 2022

A lifelong sports fan, Andrew Freese, MD, offers cutting-edge sports medicine to individuals and sports teams in Texas.

Key Points: 
  • A lifelong sports fan, Andrew Freese, MD, offers cutting-edge sports medicine to individuals and sports teams in Texas.
  • He treats complex sports injuries at AOA Orthopedic Specialists and the University of Texas Arlington, the most extensive Orthopedic Practice in Northern Texas.
  • AOA Orthopedic Specialists, founded in 1996, is known for its all-inclusive approach to spine medicine, orthopedic care, physical therapy, and sports injury medicine.
  • Dr. Freese would like to dedicate this honorable recognition to Ernie Fernandez, MD, the doctor's pediatrician and inspiration in becoming a physician.

Healthtech Leader Eon Announces New Board of Director Members

Retrieved on: 
Tuesday, May 24, 2022

DENVER, May 24, 2022 /PRNewswire/ -- Denver-based healthtech leader Eon announced today the appointment of Kevin Hutchinson and Dan Rieber to the Eon Board of Directors. Mr. Hutchinson and Mr. Rieber join current board members founder and co-CEO, Dr. Aki Alzubaidi, co-CEO Christine Spraker, and investment growth partner Ryan Anderson.

Key Points: 
  • DENVER, May 24, 2022 /PRNewswire/ -- Denver-based healthtech leader Eon announced today the appointment of Kevin Hutchinson and Dan Rieber to the Eon Board of Directors.
  • Mr. Hutchinson and Mr. Rieber join current board members founder and co-CEO, Dr. Aki Alzubaidi, co-CEO Christine Spraker, and investment growth partner Ryan Anderson.
  • "The depth of knowledge and experience that both bring to Eon will be invaluable as we work to make patients healthier and healthcare affordable.
  • Eon, founded in 2015, uses symbolic artificial intelligence to change the outcome for patients with findings that could potentially be catastrophic.

Prevent Blindness Declares Third Annual Inherited Retinal Disease (IRD) Genetic Testing Week as May 16-22

Retrieved on: 
Wednesday, May 11, 2022

CHICAGO, May 11, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading nonprofit eye health and safety organization, has declared May 16-22, 2022 as the third annual "Inherited Retinal Disease (IRD) Genetic Testing Week." Educational materials, such as a fact sheet, social media graphics, and a dedicated webpage, preventblindness.org/inherited-retinal-diseases/, are available.

Key Points: 
  • CHICAGO, May 11, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's leading nonprofit eye health and safety organization, has declared May 16-22, 2022 as the third annual "Inherited Retinal Disease (IRD) Genetic Testing Week."
  • For the third consecutive year, IRD Genetic Testing Week at Prevent Blindness is supported by Spark Therapeutics , a fully integrated company and member of the Roche group dedicated to challenging the inevitability of genetic disease.
  • Inherited Retinal Diseases, also referred to as inherited retinal disorders, are a group of diseases that can cause severe vision loss or even blindness.
  • "Through early detection, specifically through genetic testing, and treatment, severe vision loss and blindness from Inherited Retinal Diseases can be avoided in many cases," said Jeff Todd, president and CEO of Prevent Blindness.

Andrew Freese, MD, is recognized by Continental Who's Who

Retrieved on: 
Saturday, February 5, 2022

A lifelong sports fan, Andrew Freese, MD, offers cutting-edge sports medicine to individuals and sports teams in Texas.

Key Points: 
  • A lifelong sports fan, Andrew Freese, MD, offers cutting-edge sports medicine to individuals and sports teams in Texas.
  • He treats complex sports injuries at AOA Orthopedic Specialists and the University of Texas Arlington, the most extensive Orthopedic Practice in Northern Texas.
  • AOA Orthopedic Specialists, founded in 1996, is known for its all-inclusive approach to spine medicine, orthopedic care, physical therapy, and sports injury medicine.
  • As a sports medicine physician, Dr. Freese treats people of all ages who have incurred sports injuries.

Online Proctoring Leader Welcomes Information Security Expert to Support Exam Integrity Efforts

Retrieved on: 
Tuesday, February 1, 2022

"Shari's deep experience in the information security field, and her expertise at the intersection of security and assessment, will uniquely equip her to support Examity's proctoring efforts with customers across the country and around the globe."

Key Points: 
  • "Shari's deep experience in the information security field, and her expertise at the intersection of security and assessment, will uniquely equip her to support Examity's proctoring efforts with customers across the country and around the globe."
  • Her previous experience includes 5 years in the educational and workforce assessment business, as the Associate Vice President of Information Security for the pioneering testing organization ACT.
  • In her new role, Lewison will be responsible for overall information security at Examity within both its proctoring application and its broader corporate environment.
  • "Examity has long been recognized as a leader in information security, and I look forward to working with education and certification providers worldwide to ensure integrity in their testing practices."